Dow Up 0.66% Nasdaq Up 0.88%

Pernix Therapeutics Holdings, Inc. (PTX)

-NasdaqGM
0.98 Up 0.23(31.26%) 4:00PM EDT
|After Hours : 1.06 Up 0.08 (7.66%) 7:57PM EDT
Prev Close:0.75
Open:1.28
Bid:1.05 x 2500
Ask:1.09 x 9300
1y Target Est:6.67
Beta:1.57952
Next Earnings Date: 5-May-16PTX Earnings announcement
Day's Range:0.90 - 1.39
52wk Range:0.73 - 7.10
Volume:28,393,250
Avg Vol (3m):1,609,020
Market Cap:62.92M
P/E (ttm):N/A
EPS (ttm):-1.57
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Featured on Yahoo Finance

Headlines

» More Headlines for PTX

Comparison

Symbol% ChgMkt Cap
PTXUp 31.26%62.92M
JNJUp 0.60%311.00B
PFEUp 0.28%203.09B

Key Statistics

Forward P/E (1 yr):2.34
P/S (ttm):0.25
Ex-Dividend Date:21-Aug-01

Analysts

Annual EPS Est (Dec-16) :0.09
Quarterly EPS Est (Mar-16) :-0.06
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):2.17

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products. The company’s products comprise Treximet, a medication indicated for the acute treatment of migraine a... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback